Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Jiang Zhong PharmaceuticalLtd Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 6/6
Jiang Zhong PharmaceuticalLtd has a total shareholder equity of CN¥4.5B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥6.1B and CN¥1.7B respectively. Jiang Zhong PharmaceuticalLtd's EBIT is CN¥850.5M making its interest coverage ratio -11.4. It has cash and short-term investments of CN¥1.1B.
Anahtar bilgiler
0%
Borç/özkaynak oranı
CN¥0
Borç
| Faiz karşılama oranı | -11.4x |
| Nakit | CN¥1.15b |
| Eşitlik | CN¥4.48b |
| Toplam yükümlülükler | CN¥1.67b |
| Toplam varlıklar | CN¥6.14b |
Son finansal sağlık güncellemeleri
Güncelleme yok
Recent updates
Jiang Zhong Pharmaceutical Co.,Ltd (SHSE:600750) Analysts Just Slashed This Year's Revenue Estimates By 11%
Sep 12
Lacklustre Performance Is Driving Jiang Zhong Pharmaceutical Co.,Ltd's (SHSE:600750) Low P/E
Jul 20A Look At The Fair Value Of Jiang Zhong Pharmaceutical Co.,Ltd (SHSE:600750)
May 22Why Investors Shouldn't Be Surprised By Jiang Zhong Pharmaceutical Co.,Ltd's (SHSE:600750) Low P/E
Apr 15Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 600750's short term assets (CN¥2.2B) exceed its short term liabilities (CN¥1.6B).
Uzun Vadeli Yükümlülükler: 600750's short term assets (CN¥2.2B) exceed its long term liabilities (CN¥102.4M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 600750 is debt free.
Borcun Azaltılması: 600750 had no debt 5 years ago.
Borç Kapsamı: 600750 has no debt, therefore it does not need to be covered by operating cash flow.
Faiz Kapsamı: 600750 has no debt, therefore coverage of interest payments is not a concern.